University of Wisconsin–Madison Medical College of Wisconsin

Fibrocartilaginous Embolism Spinal Cord Infarction, Mistaken for Glial Fibrillary Acidic Protein Autoimmune Transverse Myelitis: A Case Report

Felix E. Chukwudelunzu, MD, MBA; Timothy Young, MD

WMJ. 2025;124(1):63-66.

Download full-text pdf.

ABSTRACT

Introduction: Fibrocartilaginous embolism causing spinal cord infarct is rare, and a high index of clinical suspicion is needed for accurate diagnosis.

Case Presentation: A 65-year-old woman presented to our hospital with back pain, paraparesis, and neurogenic bladder. Magnetic resonance imaging showed a T4-T7 signal abnormality that was misdiagnosed initially and treated as autoimmune myelitis.

Discussion: Fibrocartilaginous spinal cord infarction is rare and remains a clinical diagnosis with supportive imaging findings. The imaging findings may be nonspecific, and other etiologic diagnostic considerations must be excluded.

Conclusion: Fibrocartilaginous embolism causing spinal cord infarct can be mistaken for transverse myelitis. A high index of clinical suspicion with clinical and radiologic correlation is necessary to make accurate diagnosis and avoid unnecessary treatment.


Author Affiliations: Department of Neurology, Mayo Clinic Health System, Eau Claire, Wisconsin (Chukwudelunzu, Young).
Corresponding Author: Felix E Chukwudelunzu, MD, MBA, FAHA, FAAN, Department of Neurology, Mayo Clinic Health System, 1400 Bellinger St, Eau Claire, WI 54702; phone 715.838.1900; email chukwudelunzu.felix@mayo.edu; ORCID ID 0000-0002-0691-4570.
Funding/Support: None declared.
Financial Disclosures: None declared.
Share WMJ